Adjuvant treatment of ovarian carcinoma with tranexamic acid.
D000230:Adenocarcinoma / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D003537:Cystadenoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D010960:Plasminogen Activators / Q000378:metabolism; D014148:Tranexamic Acid / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid; D010960:Plasminogen Activators